Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Brooks

Showing results (231-240 of 1,037) with videos related to

Pageof 104
Sort By:
WMJ : Official Publication of the State Medical Society of Wisconsin|May 8, 2024
Interfacility Ambulance Versus Helicopter Transport of Traumatic Spinal Cord Injury Patients: Outcomes, Observations, and UtilizationRobert C Sterner, Nathaniel P Brooks
Journal of Speech, Language, and Hearing Research : JSLHR|February 24, 2001
Factors affecting young children's use of pronouns as referring expressionsA L Campbell, P Brooks, M Tomasello
The American Journal of Physiology|September 1, 1973
Vagal stimulation, gastrin release, and acid secretion in anesthetized dogsG Lanciault, C Bonoma, F P Brooks
Journal of Hypertension|March 14, 2007
Antioxidant activity of carvedilol in cardiovascular diseaseParesh Dandona, Husam Ghanim, David P Brooks
Current Opinion in Rheumatology|May 1, 1994
Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and penicillamineL Girgis, P G Conaghan, P Brooks
Allergy and Asthma Proceedings|February 3, 2016
A 73-year-old woman with persistent diarrhea and onychomycosisLarisa Buyantseva, Joel P Brooks, Timothy Craig
Neurosurgery|August 10, 2016
Letter: The Impact of Guidelines on Clinical Practice: Survey of the Use of Methylprednisolone for Acute Spinal Cord InjuryNathaniel P Brooks, Eric Potts, John OʼToole
Current Opinion in Rheumatology|June 3, 1998
Disease-modifying antirheumatic drugsE Li, P Brooks, P G Conaghan
The Journal of Allergy and Clinical Immunology. in Practice|May 20, 2020
The Future of Telehealth in Allergy and Immunology TrainingAnjeni Keswani, Joel P Brooks, Paneez Khoury
Ophthalmic Genetics|July 5, 2019
Participant perspectives on a phase I/II ocular gene therapy trial (NCT02077361)Stephanie P Brooks, Shelly Benjaminy, Tania Bubela
Pageof 104

Showing results (231-240 of 1,037) with videos related to

Sort By:
Pageof 104
WMJ : Official Publication of the State Medical Society of Wisconsin|May 8, 2024
Interfacility Ambulance Versus Helicopter Transport of Traumatic Spinal Cord Injury Patients: Outcomes, Observations, and UtilizationRobert C Sterner, Nathaniel P Brooks
Journal of Speech, Language, and Hearing Research : JSLHR|February 24, 2001
Factors affecting young children's use of pronouns as referring expressionsA L Campbell, P Brooks, M Tomasello
The American Journal of Physiology|September 1, 1973
Vagal stimulation, gastrin release, and acid secretion in anesthetized dogsG Lanciault, C Bonoma, F P Brooks
Journal of Hypertension|March 14, 2007
Antioxidant activity of carvedilol in cardiovascular diseaseParesh Dandona, Husam Ghanim, David P Brooks
Current Opinion in Rheumatology|May 1, 1994
Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and penicillamineL Girgis, P G Conaghan, P Brooks
Allergy and Asthma Proceedings|February 3, 2016
A 73-year-old woman with persistent diarrhea and onychomycosisLarisa Buyantseva, Joel P Brooks, Timothy Craig
Neurosurgery|August 10, 2016
Letter: The Impact of Guidelines on Clinical Practice: Survey of the Use of Methylprednisolone for Acute Spinal Cord InjuryNathaniel P Brooks, Eric Potts, John OʼToole
Current Opinion in Rheumatology|June 3, 1998
Disease-modifying antirheumatic drugsE Li, P Brooks, P G Conaghan
The Journal of Allergy and Clinical Immunology. in Practice|May 20, 2020
The Future of Telehealth in Allergy and Immunology TrainingAnjeni Keswani, Joel P Brooks, Paneez Khoury
Ophthalmic Genetics|July 5, 2019
Participant perspectives on a phase I/II ocular gene therapy trial (NCT02077361)Stephanie P Brooks, Shelly Benjaminy, Tania Bubela
Pageof 104